Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The study is an open label, randomized phase 3 study of MM-398 with or without 5-Fluorouracil
(5-FU) and Leucovorin (also known as folinic acid), versus 5-FU and leucovorin in metastatic
pancreatic cancer patients who have progressed on prior gemcitabine based therapy.